Concert Pharma (CNCE) Misses Q4 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update
March 3, 2022 6:00 AM ESTTwo Phase 3 Registrational Clinical Trials Fully Enrolled for CTP-543 for the Treatment of Alopecia Areata
CTP-543 THRIVE-AA1 Phase 3 Trial Topline Data Expected Second Quarter of 2022
CTP-543 THRIVE-AA2 Phase 3 Trial Topline Data Expected Third Quarter of 2022
Conference Call Scheduled Today at 8:30 a.m. ET
LEXINGTON, Mass.--(BUSINESS... More
